Advocacy 

The Leukemia & Lymphoma Society (LLS) advocates public policy positions that accelerate progress toward cures for leukemia, Hodgkin and non-Hodgkin lymphoma and myeloma.

The aim of LLS's advocacy program is to improve the quality of life of those with blood cancer, their friends and families. Critical elements of this effort are:

• Ensuring patients access to high quality healthcare
• Creating a positive climate for research into leukemia, lymphoma and myeloma

Each year Volunteers and Staff from The Leukemia & Lymphoma Society (pictured above), descend on Capitol Hill to lobby Congress in an effort to further the Society's legislative agenda.   

LLS endorses:

• Increased federal funding for biomedical research
• Collaborative public-private sector research efforts
• Patient protection legislation that guarantees all healthcare consumers certain fundamental rights, including the right to care in a clinical trial

To advance its policy goals, LLS encourages its volunteers, friends and other supporters to contact their elected representatives - in Congress and in state legislatures - to share with them the impact that leukemia, lymphoma and myeloma have on millions of Americans each year and to urge responsible policies that will address the serious burdens of these diseases.

Advocacy at the Society - Find out what it takes to be an advocate for The Leukemia & Lymphoma Society

Action Center - Get to know your representatives in the House of Representatives and the Senate

Legislative Priorities & Position Statements - The Leukemia & Lymphoma Society offers public policy positions on relevant legislative matters and Advocacy Updates

Toolbox for Advocates - All of the necessary tools for advocacy volunteers to effectively communicate issues to their legislators and have effective legislative visits

Volunteer - This page is for the public to sign up to become Advocates for The Leukemia & Lymphoma Society.

Advocacy Teleconference- Informational teleconferences on current issues regarding blood cancer research funding and patient access to quality health care